G4376
L -氧化谷胱甘肽
≥98% (HPLC)
别名:
GSSG, 氧化谷胱甘肽
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C20H32N6O12S2
化学文摘社编号:
分子量:
612.63
MDL number:
UNSPSC Code:
12161501
NACRES:
NA.21
PubChem Substance ID:
EC Number:
248-170-7
Beilstein/REAXYS Number:
1718700
Quality Level
assay
≥98% (HPLC)
form
powder
solubility
H2O: soluble
storage temp.
2-8°C
SMILES string
N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O
InChI
1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1
InChI key
YPZRWBKMTBYPTK-BJDJZHNGSA-N
General description
我们的SAFC®高质量原材料产品组合用于生物制药工艺，可通过严苛的质控程序并提供配套文档和技术专长，帮助客户满足 M-Clarity 计划规定的要求。
M-Clarity 计划
我们全面的下游工艺化学品产品组合不仅为生物制药制造商提供生产传统和新型治疗制剂所需的优质原材料，还可帮助他们加速产品上市并简化监管问题。
从低风险应用的非GMP等级，到高风险应用的 IPEC-PQG GMP，我们的产品可满足您的所有制造需求。
M-Clarity 计划
我们全面的下游工艺化学品产品组合不仅为生物制药制造商提供生产传统和新型治疗制剂所需的优质原材料，还可帮助他们加速产品上市并简化监管问题。
从低风险应用的非GMP等级，到高风险应用的 IPEC-PQG GMP，我们的产品可满足您的所有制造需求。
Legal Information
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under L -氧化谷胱甘肽
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
动植物源性产品
此项目有
Katharina Herzog et al.
Metabolites, 9(3) (2019-03-08)
Oxidative stress plays a role in the onset and progression of a number of diseases, such as Alzheimer's disease, diabetes and cancer, as well as ageing. Oxidative stress is caused by an increased production of reactive oxygen species and reduced
N O Kaakoush et al.
Antimicrobial agents and chemotherapy, 53(5), 1884-1891 (2009-02-19)
Metronidazole resistance in Helicobacter pylori has been attributed to mutations in rdxA or frxA. Insufficient data correlating RdxA and/or FrxA with the resistant phenotype, and the emergence of resistant strains with no mutations in either rdxA or frxA, indicated that
Roman Kireev et al.
European journal of pharmacology, 701(1-3), 185-193 (2012-12-12)
Fatty livers occur in up to 20% of potential liver donors and increase cellular injury during the ischemia/reperfusion phase, so any intervention that could enable a better outcome of grafts for liver transplantation would be very useful. The effect of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| G4376-100G | 04061833630716 |
| G4376-1G | 04061833630747 |
| G4376-250MG | 04061833630792 |
| G4376-10G | 04061833630730 |
| G4376-1KG | 04061826682685 |
| G4376-500MG | 04061833630822 |
| G4376-5G | 04061833630846 |